- Home
- / JW Holdings
JW Holdings
Revenue
₩969.6 B
FY, 2025
JW Holdings Summary
Company Summary
- Overview
- JW Holdings is a healthcare solutions provider. Its products comprised of antimicrobials, antifungals, anticancer and gastrointestinal agents. The company's focus areas are raw material, completion medicine, medical supplies and medical appliances.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- KR | view all locations
- Website
- https://jw-holdings.co.kr
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
LocationsView all
1 location detected
Seoul HQ
Korea (Republic of)
2477 Nambusunhwan-ro, Seocho-dong, Seocho-gu
JW Holdings Financials
Summary Financials
- Revenue (FY, 2025)
- ₩969.6B
- Gross profit (FY, 2025)
- ₩523.3B
- Net income (FY, 2025)
- ₩115.5B
- Cash (FY, 2025)
- ₩71.8B
- EBIT (FY, 2025)
- ₩162.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026